Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Payables (2016 - 2025)

Utah Medical Products has reported Payables over the past 16 years, most recently at $911000.0 for Q4 2025.

  • Quarterly results put Payables at $911000.0 for Q4 2025, up 30.89% from a year ago — trailing twelve months through Dec 2025 was $911000.0 (up 30.89% YoY), and the annual figure for FY2025 was $911000.0, up 30.89%.
  • Payables for Q4 2025 was $911000.0 at Utah Medical Products, up from $768000.0 in the prior quarter.
  • Over the last five years, Payables for UTMD hit a ceiling of $1.5 million in Q1 2022 and a floor of $511000.0 in Q3 2023.
  • Median Payables over the past 5 years was $912500.0 (2025), compared with a mean of $954600.0.
  • Biggest five-year swings in Payables: surged 111.79% in 2021 and later crashed 60.36% in 2023.
  • Utah Medical Products' Payables stood at $761000.0 in 2021, then soared by 60.05% to $1.2 million in 2022, then crashed by 36.86% to $769000.0 in 2023, then dropped by 9.49% to $696000.0 in 2024, then surged by 30.89% to $911000.0 in 2025.
  • The last three reported values for Payables were $911000.0 (Q4 2025), $768000.0 (Q3 2025), and $737000.0 (Q2 2025) per Business Quant data.